AstraZeneca selects location for brand-new global R&D center and corporate headquarters AstraZeneca announced that its brand-new UK-based global study and development center and corporate headquarters will end up being located at the Cambridge Biomedical Campus on the southern outskirts of the town . By 2016, the brand new site will home a highly-experienced workforce of around 2,000. The purpose-constructed site in Cambridge provides together AstraZeneca’s little molecule and biologics study and development activity, checking possibilities to exploit the guarantee of large and little molecule combinations.

AstraZeneca PLC Fourth One fourth and Full Year Outcomes 2008 AstraZeneca has delivered a robust performance within an challenging marketplace environment increasingly. Good headway has been made in additional improving the performance of the business, and the growth in the scope of our restructuring initiatives is another important stage towards sustaining long-term competitiveness. Sales in the 4th quarter increased by 4 % at CER, but had been unchanged on an as reported basis due to the negative influence of exchange rate motions. Sales in america had been up 3 %, because the adverse impact from generic competition for Toprol-XL is annualised now.